A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury

We performed genetic analyses of a multiethnic cohort of patients with idiosyncratic drug-induced liver injury (DILI) to identify variants associated with susceptibility.

This entry was posted in News. Bookmark the permalink.